Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Petmed Express Inc (PETS): Could This Online Pet Supplier Join the Seattle Web Giant’s Empire?

Petmed Express Inc (NASDAQ:PETS), Inc. (NASDAQ:AMZN)’s primary focus may be on its Kindle technology and digital media franchise, but it continues to add products to the world’s largest marketplace. When building product categories are not cost effective, it acquires value-enhancing brands, like its purchase of online shoe purveyor Zappos.

With $52 billion in annual sales, the pet products business is also on the company’s radar, which it participates in through multiple channels including its unit. However, in a bid to put competitors in the rear-view mirror, could the leading pet pharmacy owner Petmed Express Inc (NASDAQ:PETS) be on, Inc. (NASDAQ:AMZN)’s list of targets?

What’s the value?

Founded in 1996, Petmed Express Inc (NASDAQ:PETS) offers a broad assortment of prescription and non-prescription pet medications, as well as pet supplies, through its namesake website and call centers. The company has been aided by rising per capita spending by pet owners on their canine and feline friends, with the American Pet Products Manufacturers Association estimating that 2012 industry sales were $52.9 billion, up 4.7% versus the prior year. Petmed Express Inc (NASDAQ:PETS) has also benefited from consumers’ continual search for the best price, which the company delivers by capitalizing on its volume purchase discounts.

In its latest fiscal year, Petmed Express Inc (NASDAQ:PETS) posted mixed results, with a 4.4% decline in total revenue, but a 3.9% increase in operating income. The company’s top-line was hurt by a lower average customer order size and the unavailability of certain popular products due to manufacturer production delays. On the upside, PetMed Express’ operating margin received a boost from lower advertising spending, as management pursued lower cost, online advertising channels.

Given Petmed Express Inc (NASDAQ:PETS)’ rising customer acquisition costs, up 5% for the period, the company could get significant mileage from being part of, Inc. (NASDAQ:AMZN)’s network of properties and its ubiquitous brand recognition. The internet giant could certainly reverse Petmed Express Inc (NASDAQ:PETS)’ declining operating margin by leveraging its own efficient fulfillment and marketing operations, thereby driving a greater percentage of gross profit to the bottom line. At a current price to operating profit multiple of 11, an acquisition would be a relatively cheap way for Amazon to gain the top position in the pet medications segment.

Knocking on the door

Of course, pet retailing giant PetSmart, Inc. (NASDAQ:PETM) has the most to lose from Amazon’s growing ambitions in the pet products space. The company is the largest specialty retailer focused on the pet sector, with over 1,200 stores in the U.S., Canada, and Puerto Rico as of December 2012. However, PetSmart, Inc. (NASDAQ:PETM) generates over half of its total sales from the consumables product area, like food and nutritional items, which are susceptible to cheaper prices from online competitors.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.